The effects of Captopril and placebo were compared in 18 patients with chronic heart failure
and angina pectoris with use of a double-blind crossover trial design. Symptoms were …

The hemodynamic effects of an oral angiotensin-converting enzyme inhibitor, captopril, were
evaluated in 10 symptomatic patients with chronic congestive heart failure. In all patients …

Although many studies have shown acute hemodynamic improvement in patients with
congestive heart failure treated with vasodilating drugs, long-term controlled studies with …

The effect of the converting enzyme inhibitor captopril as long term treatment was
investigated in 14 patients with severe congestive heart failure in a double blind trial …

SUMMARY Captopril (SQ 14,225), an oral angiotensin converting-enzyme inhibitor, was
administered to 11 patients with severe congestive heart failure (CHF). Peak effect was …

The acute hemodynamic effects, long-term clinical efficacy, and safety of the oral
angiotensin-converting enzyme inhibitor, captopril, were assessed in a multicenter …

The 6-month extended vasodilator efficacy of the oral angiotensin converting enzyme (ACE)
inhibitor, captopril (CPT), was evaluated by sequential cardiac catheterization, nuclear …

The hemodynamic effects of captopril (SQ 14225), an oral inhibitor of angiotensin-converting
enzyme, were measured in 10 patients with severe chronic heart failure poorly controlled by …

BACKGROUND Treatment with angiotensin converting enzyme inhibitors has been shown
to be beneficial in patients with heart failure and myocardial infarction. Experimental studies …

Ninety-two patients with heart failure refractory to digitalis and diuretic therapy had Captopril
(n= 50) or placebo (n= 42) added to their therapeutic regimen in a randomized, double-blind …